Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for <i>Helicobacter pylori</i> eradication: A randomized controlled trial-Reference-Cited by-同舟云学术

Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial

Published:2022-11-14 Issue:1 Volume:28 Page:
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Tian Xue‐li¹,Suo Bao‐jun¹,Zhang Hua²,Lu Hao‐ping¹,Li Cai‐ling¹,Zhang Yu‐xin¹,Ren Xin‐lu¹,Yao Xing‐yu¹,Zhou Li‐ya¹^ORCID,Song Zhi‐qiang¹^ORCID

Affiliation:

1. Department of Gastroenterology Peking University Third Hospital Beijing China

2. Research Center of Clinical Epidemiology Peking University Third Hospital Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hel.12935

Reference31 articles.

1. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

2. Kyoto global consensus report onHelicobacter pylorigastritis

3. Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

4. Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship

5. Fifth Chinese National Consensus Report on the management ofHelicobacter pyloriinfection

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world efficacy of second-line therapies for Helicobacter pylori: a population-based study;Journal of Antimicrobial Chemotherapy;2024-07-08

2. Tailored therapy guided by genotypic resistance of clarithromycin and levofloxacin detected by polymerase chain reaction in the first‐line treatment of Helicobacter pylori infection;Journal of Digestive Diseases;2024-01

3. The benefit of the bismuth add-on to the 2-week clarithromycin-based triple regimen for Helicobacter pylori eradication: a propensity score-matched retrospective study;Gut Pathogens;2023-03-19